Published in J Hepatobiliary Pancreat Surg on April 06, 2008
Portosystemic Shunts for "Too Small-for-Size Syndrome" After Liver Transplantation: A Systematic Review. World J Surg (2016) 1.08
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts. World J Gastroenterol (2014) 0.84
Somatostatin and propranolol for the treatment of small-for-size syndrome after liver transplantation. J Hepatobiliary Pancreat Surg (2008) 0.76
Impact of mesocaval shunt on safe minimal liver remnant: porcine model. World J Gastroenterol (2013) 0.76
Sonographic evaluation of vessel grafts in living donor liver transplantation recipients of the right lobe. World J Gastroenterol (2009) 0.75
Adult to adult right lobe living donor liver transplantation: does biological relationship matter? Medicine (Baltimore) (2017) 0.75
Efforts to expand the donor pool for liver transplantation. F1000 Med Rep (2010) 0.75
A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio. Transplantation (2016) 0.75
Development of Spontaneous Bacterial Peritonitis after Extended Hepatic Resection in a Patient without Evidence of Liver Cirrhosis. Gut Liver (2010) 0.75
Hepatic Arterial Buffer Response Maintains the Homeostasis of Graft Hemodynamics in Patient Receiving Living Donor Liver Transplantation. Dig Dis Sci (2015) 0.75
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol (2012) 1.84
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res (2003) 1.79
Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem (2004) 1.78
Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation (2009) 1.69
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg (2014) 1.65
Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol (2010) 1.59
Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol (2002) 1.58
Reconstruction of the middle hepatic vein tributaries using the recipient's recanalized umbilical vein in right-lobe living-donor liver transplantation. Surgery (2006) 1.58
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res (2004) 1.58
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg (2013) 1.56
Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation (2008) 1.51
Risk factors that increase mortality after living donor liver transplantation. Transplantation (2012) 1.51
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J Hepatol (2010) 1.48
The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation (2009) 1.42
A new technique to acquire additional liver volume for left lobe graft in living donor liver transplantation. Hepatogastroenterology (2008) 1.42
Selection of a right posterior sector graft for living donor liver transplantation. Liver Transpl (2014) 1.38
Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38
Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg (2007) 1.37
Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas (2008) 1.33
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology (2003) 1.29
Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today (2008) 1.28
Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol (2012) 1.18
Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett (2005) 1.18
Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst (2006) 1.16
Rapid-growing solitary necrotic nodule of the liver. J Med Invest (2006) 1.15
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol (2011) 1.13
Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection. Surg Endosc (2012) 1.12
Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer (2003) 1.12
The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int (2008) 1.12
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation (2009) 1.10
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol (2009) 1.10
Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation (2007) 1.10
Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol (2010) 1.09
Establishment of regional alliance clinical pathways for gastrointestinal cancer in Tokushima. Fukuoka Igaku Zasshi (2011) 1.09
Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database. J Gastroenterol (2013) 1.09
Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl (2014) 1.07
Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg (2014) 1.07
Accurate preoperative estimation of liver-graft volumetry using three-dimensional computed tomography. Transplantation (2003) 1.05
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas (2006) 1.05
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol (2010) 1.04
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy. Cancer Chemother Pharmacol (2013) 1.03
Biliary strictures in living donor liver transplantation: incidence, management, and technical evolution. Liver Transpl (2006) 1.03
Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology (2003) 1.03
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03
Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol (2009) 1.02
Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A (2008) 1.02
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery (2002) 1.01
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev (2004) 1.01
The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection. Surg Today (2011) 1.01
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology (2002) 1.01
Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology (2006) 1.00
The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep (2003) 1.00
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study). Jpn J Clin Oncol (2009) 0.99
Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl (2003) 0.99
Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99
Significance of sonic hedgehog signaling after massive hepatectomy in a rat. Surg Today (2012) 0.98
Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today (2010) 0.98
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98
Kampo medicine "Dai-kenchu-to" prevents bacterial translocation in rats. Dig Dis Sci (2008) 0.98
New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation. Transplantation (2015) 0.97
Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation. Transpl Int (2005) 0.97
Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg (2015) 0.97
Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96
Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe. Am J Surg (2005) 0.96
Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res (2010) 0.96
Graft-versus-host disease following living donor liver transplantation. Liver Transpl (2004) 0.96
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001). Int J Clin Oncol (2014) 0.96
A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol (2014) 0.95
Laparoscopic removal of a foreign body in the pelvic cavity through one port using a flexible cholangioscope. Dig Surg (2009) 0.95
Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol (2014) 0.95
Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg (2009) 0.95
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology (2008) 0.94
Hepatic screlosed hemangioma which was misdiagnosed as metastasis of gastric cancer: report of a case. J Med Invest (2012) 0.94
Left lobe living donor liver transplantation in an adult patient with situs inversus: technical considerations. Transpl Int (2008) 0.94